Wednesday, July 14, 2021 9:02:58 AM
Los Angeles, CA, July 14, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- HQ
Global Education, Inc. (OTC: HQGE) reported today that the company has
reported all required financials and has now been returned to “Current
Information” status on OTC Markets. The company also reported that its total
number of outstanding common shares has just been reduced by another 550
million shares, from 7,969,922,441 down to 7,419,922,441. This share reduction
occurred as a result of Marvin Williams, President of HQGE and CEO of its
operating subsidiary Big M Entertainment Pictures (BMEP), voluntarily
returning an additional 550 million of his personally owned shares to HQGE’s
treasury. Mr. Williams had previously returned 550 million shares in March
2021, bringing the total number of shares he has returned this year to 1.1
billion.
HQGE’s CEO Daniel Gallardo Wagner commented, “We are very pleased to make
these announcements. We believe our return to Current Status on OTC Markets,
along with this significant reduction of our outstanding common shares, not
only strengthens our position in the marketplace but also signals to the world
that HQGE and Big M Entertainment are continuing to move forward and adapt to
today’s economic environment in ways that will benefit our shareholders.”
Mr. Williams stated, “My decision to voluntarily retire an additional 550
million shares at this time and in conjunction with HQGE’s return to Current
Information status is my way of confirming my personal commitment to the
overall success of the company. BMEP continues to make significant strides
both in moving our current Intellectual Property towards completion and
release and by continuing to add additional Intellectual Product to our
portfolio. We have many projects in development now and look forward to
releasing more news in the very near future.”
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM